Ukwenza ukhetho olunolwazi malunga ne- multiple sclerosis yakho (MS) unyango lweziyobisi luqala ngokukwazi amaqiniso. Kwezinye iimeko, ukhetho lunokukhawulelwa ngenxa yesigaba sesifo sakho, ubunzima beempawu, okanye nayiphina imithi yonyango ongaphambili oye wafunyanwa kuyo.
I-Avonex (i-interferon beta-1a) yindlela enye echazwe kwizifo zakuqala. Njengoko yonke imishanguzo ye-MS, inezibonelelo zayo kunye neziphene.
Iinkcazo
I-Avonex (i-interferon beta-1a) isicirisi esisinyakatho esilungisa i-intereferononi ephantsi kakhulu. Yavunywe yi-US Food Management and Drug Administration ngo-1996 ukuze isebenziswe kubantu abanezifo ezisekuqaleni-ezibizwa ngokuba yi-MS yokubuyisela kwakhona (i-RRMS) okanye abo bafumana ukuhlaselwa kwe-MS kodwa bengayifumani imigaqo yokuxilongwa kwe-MS .
Impumelelo
Ukususela kwimiba yokubala, yonke into ebizwa ngokuba yi-CRAB ( iCopaxone , Rebif , Avonex, i- Betaseron ) yinto enempumelelo kakhulu, inciphisa umngcipheko wokubuyela kwakhona kubantu abane-RRMS malunga neyesithathu.
Uphando lwe-klinikhi yangaphambi kweemveliso lubonise ukuba i-Avonex inganciphisa umngcipheko we-MS uphinde uhlawule ngamaphesenti angama-32 kubantu abane-RRMS enokumodareyitha. Ezinye iziphumo zokuthengisa iimveliso ziye zaphazamisa ukusetyenziswa kwezidakamizwa phakathi kweepesenti ezingama-19 kunye neepesenti ezingama-38, (ukuhluka kwaso kunokuchazwa ngexesha elide lezilingo kunye / okanye uluntu lwabafundi).
I-Avonex ayibonakali iyasebenza ngaphaya kwexesha.
Kukho ubungqina, nangona kunjalo, ukuba i-interferons dose ephezulu njengeRebif inokusebenza ngakumbi kwezinye. Ngaloo ndlela, iRebif idlalwa ngokuqhelekileyo njengonyango lwangowesibini ukuba umntu uye wafumana ukuphindaphinda kwakhona kwi-Avonex.
Lawulo
Oogqirha abaninzi kunye nezigulane zikhetha i-Avonex njengonyango lokuqala lomgca kuba ifuna enye injenki nganye ngeveki ngokuchasene neyesithathu ukuya kwezixhenxe ezifunekayo kwezinye iziyobisi.
I-dose ye-week-once iyanciphisa amaninzi emiphumo efana nefuthe, evumela abantu ukuba bathabathe iField ngoLwesihlanu baze bafikelele ngeveki.
Oku kwenza uVonex ukhetho oluhle kubantu abasebenza ngexesha elipheleleyo, banakekela abantwana abancinci, okanye banemiba eyanciphisa ixesha eliphantsi lokufumaneka kwabo. Ishedyuli ye-dosing iphinda ibhenele abantu abangenakulungele ukuzijoca. Kunoko, ukutyelela i-ofisi rhoqo kunokucwangciswa (oku kungaqinisekisa ukunyanzelwa kokunyanga, ngokunjalo).
Ngokuchasene nezinye iziyobisi ezithunyelwa ngaphantsi (phantsi kwesikhumba), i-Avonex kufuneka inikwe i- intramuscularly (ngokuqhelekileyo ibe yintsimbi). Kwinqanaba elincinci, kukho i-redness okanye ukuvuvukala kwi-site injection.
Ngokufanelekileyo, ijoyilo kufuneka inikwe ngosuku olufanayo ngeveki, nangona ingaba sisondele kwiintsuku ezintlanu okanye ixesha elide kwiintsuku ezili-10 xa kufuneka.
Imiphumela
Imiphumo emibi ye-Avonex ifana nezinye iirhofer-based based and can often show with symptoms like, like:
- Fever
- IChills
- Ukuxela
- Iiscle Aches
- Ukukhathala
Inani elinamaphesenti angama-61 labantu abasebenzisa i-Avonex baya kufumana le mpawu engapheliyo ukusuka kwiiyure ezingama-24 ukuya kuma-36 ngokuqhelekileyo. Uninzi lwaba luya kuphelisa ixesha, nangona linokuhlala ixesha leenyanga ezintandathu okanye ngaphezulu ukuya kumazinga ahlukeneyo.
Ukuxinezeleka kuye kwaphawulwa kwamanye, ngokuqhelekileyo emva kokunyanga kwexesha elide.
Ukuqwalaselwa kunye nokuchasene
I-Avonex ayifanelekanga wonke umntu. Kungenzeka ukuba isetyenziswe kwabanye abantu okanye igwenywe ngokupheleleyo kwabanye. Ukuqwalasela kubandakanya:
- Abantu kwi-Avonex kufuneka bahlolwe rhoqo ukuze bahlole i-enzyme yesibindi. I-Avonex ingabangela ukuphakama kwezi-enzyme ezinokubangela ukulimala kwesibindi okanye ukuhluleka. Abantu abanezifo zesibindi esele zikhona okanye i- cirrhosis bangabi ngabaviwa abafanelekileyo kwi-Avonex kwaye kufuneka bavavanywe kwimeko ngamacala.
- I-Avonex ayifanele isetyenziswe ngabasetyhini abakhulelweyo okanye abaceba ukukhulelwa . Nangona kungekho uphando lweklinikhi yoluntu olufumanekayo ukuvavanya ingozi ebantwini ekuzalweni, iziphene zokuzalwa ziye zaphawulwa kwiinkalo ezininzi zezilwanyana. Ukuncelisa isiluleko asikwacetyiswa nawe kuwe (okanye usandul 'u) kwiVonex.
- I-Avonex kufuneka isetyenziswe ngokuqaphela kubantu abanexinzelelo lweklinikhi. Nangona kungaphikiswanga ukusetyenziswa (ngokukodwa ekubeni ingozi yokuxinezeleka iqhubela phezulu kubantu abane-MS), iqinisekisa ukuba unonophelo olukhethekileyo ukuqinisekisa ukuba ubomi bomntu abuchaphazeli kakhulu kunyango.
- Ngokufanayo, i-Avonex kufuneka isetyenziswe ngokubaluleka kubantu abaneengxaki zokubamba iimeko okanye iingxaki zengqondo njengoko zinokuba zikhuni okanye zibuhlungu ngakumbi ezi zimpawu. Kwiimeko ezinqabileyo, i-Avonex iye yaziwa ngokubangela ukuxhwaleka kunye nentliziyo yokungenakwenzeka kubantu abangenazo iimbali zangaphambili okanye izinto ezinobungozi bokubakho kwimeko.
Iindleko zonyango
Uhlobo lwexabiso le-Avonex lwamaxabiso okuthengisa nge-2017 lingaphezulu kwama-6 500 ngenyanga okanye malunga nama-81,000 ngonyaka. I-inshurensi ibandakanya ngokuyinxalenye yeendleko zonyango, nangona iindleko ze-copay kunye ne-out-of-pocket ngezinye izihlandlo ziba nzima. Iiprogram zenkxaso zonyango (i-PAPs) ziyafumaneka ukuncedisa ukubuyiswa kwezidakamizwa okanye ukuncedisa i-copay kule nto kunye nezinye iintlobo zonyango ezinomsoco.
Ukufumana ulwazi oluthe vetshe, qhagamshelana nabaNxibelelanisi beNkxaso kwi-Bionex (umenzi weziyobisi) kwi-800-456-2255 okanye uvakashele i-AboveMS.com ngolwazi olungakumbi.
> Umthombo
> Ulawulo lweZiko lokuTya kunye neDrug. " IMIGAQO EPHAKAMILEYO YOKWENZA IINKCUKACHA: I- Avonex (i-interferon beta-1a) ." Silver Spring, eMaryn; hlaziywa ngoDisemba 2015.